Rocket Lab’s Stock Takes a 25% Monthly Hit — But the Backlog Tells a Different Story
Published on 07/26/2026 at 14:11 | Redaktion boerse-global.de
Rocket Lab’s share price has been caught in a vicious downdraft, shedding 8.29% on Friday alone to close at €56.40 and racking up a 24.90% loss over the past 30 days. Yet for investors willing to look past the noise, the company’s operational momentum has rarely been stronger.
The selloff has been exacerbated by two distinct pressures. First, the stock breached a psychologically important level tied to the planned $8 billion acquisition of Iridium Communications. Second, insider sales by CEO Peter Beck rattled some market participants. But neither concern holds up under scrutiny. Beck’s sales, executed in early July, were conducted through a Rule 10b5-1 trading plan established on March 27 — a routine portfolio diversification mechanism, not a vote of no confidence.
What the market appears to be pricing in is a sector-wide rotation. The recent IPO of SpaceX, which commanded a valuation of roughly $2 trillion, has prompted institutional investors to reallocate capital away from smaller publicly traded space companies in favor of direct exposure to the industry leader. Rocket Lab, despite its own string of contract wins, has been caught in the crossfire.
A $17 Billion Contract Vehicle and a $266 Million Win
The disconnect between operational performance and stock price is stark. Last week alone, the US Air Force awarded Rocket Lab a $266 million contract for dedicated launch services. Even more consequential, the US Space Force selected the company as one of seven providers for a contract vehicle worth up to $17 billion over the coming years.
Should investors sell immediately? Or is it worth buying Rocket Lab?
These milestones should have been catalysts. Instead, they were overshadowed by the Iridium deal, which investors view with skepticism due to financing concerns and the potential for shareholder dilution. The company’s backlog now stands at a solid $2.2 billion, but the market is demanding clarity on how management intends to fund its aggressive expansion without eroding existing equity.
Technical Exhaustion, Not Fundamental Breakdown
From a chart perspective, the stock has entered deeply oversold territory. The 14-day relative strength index sits at 30.8, a level that typically signals an exaggerated selloff. The current price is 57.85% below the 52-week high of €133.80 reached on May 27, yet still 73.01% above the November 2025 low of €32.60. With an annualized 30-day volatility of 88.21%, violent swings in both directions are par for the course.
The average analyst price target stands at €100.50, implying 78.2% upside from Friday’s close. That gap between market sentiment and analyst conviction suggests the selloff is more about technical exhaustion than a reassessment of the business’s long-term prospects.
What’s Next: Fed, Earnings, and the Neutron Rocket
The immediate catalyst will be the Federal Reserve’s two-day meeting on July 28-29. A dovish outcome could provide a tailwind for growth stocks and help Rocket Lab establish a floor. But the real test comes on August 10, when the company reports second-quarter results. Investors will be looking for updates on the Iridium integration plan, progress on the Archimedes engine certification for the Neutron rocket, and any changes to the timeline for the medium-lift vehicle’s debut.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
The next Electron mission — StriX Launch 11 for Japanese earth-observation specialist Synspective — is scheduled for July 31 from Launch Complex 1 in New Zealand. A successful flight would reinforce the reliability of Rocket Lab’s workhorse rocket while the larger Neutron platform continues development.
Ultimately, the long-term investment thesis hinges on a single event: the first flight of the Neutron rocket, currently targeted for the fourth quarter of 2026. As long as that schedule holds, the current weakness looks more like a buying opportunity than a fundamental warning signal.
Ad
Rocket Lab Stock: New Analysis - 26 July
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
